Tuesday, September 01, 2020 7:59:14 AM
European approval of Libmeldy around October
Licensing agreement w/ GlaxoSmithKline $GSK
Analyst PT $17-$31
70% institutional ownership
Recent ORTX News
- Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List • GlobeNewswire Inc. • 05/03/2024 11:00:38 AM
- Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy • GlobeNewswire Inc. • 03/20/2024 11:00:07 AM
- Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S. • GlobeNewswire Inc. • 03/18/2024 07:41:13 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 02:05:44 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/05/2024 07:39:49 PM
- Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome • GlobeNewswire Inc. • 02/05/2024 12:00:03 PM
- Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium • GlobeNewswire Inc. • 02/02/2024 12:00:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/31/2024 05:15:12 AM
- Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy • GlobeNewswire Inc. • 01/25/2024 12:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:20:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:18:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:17:53 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 01/24/2024 09:41:53 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/24/2024 09:28:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:17:00 PM
- Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases • GlobeNewswire Inc. • 01/24/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:10:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:49:53 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM